المؤلفون: Talvard-Balland N; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Braun LM; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Dixon KO; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Mass General Hospital and Harvard Medical School, Boston, United States of America., Zwick M; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Engel H; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Hartmann A; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Duquesne S; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America., Andrieux G; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Freiburg, Germany., Rindlisbacher LS; Institute of Experimental Immunology, University of Zurich, Zürich, Switzerland., Acerbis A; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Ehmann J; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Köllerer C; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America., Rettig A; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Moschallski K; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Apostolova P; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brummer T; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Illert AL; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schramm MA; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Freiburg, Germany., Cheng Y; Institute of Genetic Epidemiology, Medical Center - University of Freiburg, Freiburg, Germany., Köttgen A; Institute of Genetic Epidemiology, Medical Center - University of Freiburg, Freiburg, Germany., Duyster J; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Menssen HD; BioMedical Research, Novartis Institutes for BioMedical Research Inc., Basel, Switzerland., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America., Blazar BR; Department of Pediatrics, Division of Blood & Marrow Transplant & Cellular, University of Minnesota, Minneapolis, United States of America., Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Freiburg, Germany., Schmitt Graeff A; Department of General Pathology, Institute of Pathology, University of Freiburg, Freiburg, Germany., Sariipek N; Division of Hematology, Brigham and Women's Hospital, Boston, United States of America., van Galen P; Division of Hematology, Brigham and Women's Hospital, Boston, United States of America., Buescher JM; Max-Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany., Cabezas-Wallscheid N; Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany., Pahl HL; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Pearce EL; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, United States of America., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America., Vago L; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milano, Italy., Becher B; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Köhler N; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Wertheimer T; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Kuchroo VK; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Mass General Hospital and Harvard Medical School, Boston, United States of America., Zeiser R; Department of Internal Medicine I, Medical Center - University of Freiburg, Freiburg, Germany.

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

المؤلفون: Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Murdock HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Brock J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shapiro R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bat-Erdene D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Contreras ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

المصدر: Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 978-990.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control , Sulfonamides* , Bridged Bicyclo Compounds, Heterocyclic*, Humans ; Transplantation Conditioning ; Transplantation, Homologous ; Azacitidine/therapeutic use

المؤلفون: Marchesi, F.^Aff1, Capria, S., Giannarelli, D., Trisolini, S. M., Ansuinelli, M., Caputo, M. D., Serrao, A., Gumenyuk, S., Renzi, D., Pupo, L., Palombi, F., Provenzano, I., Di Rocco, A., Pisani, F., Romano, A., Spadea, A., Papa, E., Canfora, M., Cantonetti, M., Mengarelli, A.

المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 53(8):1051-1054

المؤلفون: Cardinali D; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Beldinanzi M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Ansuinelli M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Elia L; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy.; Fondazione GIMEMA Onlus, Rome, Italy., Bellomarino V; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Matarazzo M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Di Trani M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Cola M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Salutari P; Department of Hematology Ospedale Civile, Pescara, Italy., Cedrone M; UOC Ematologia, Ospedale San Giovanni Addolorata, Rome, Italy., Bassan R; Hematology Unit, Ospedale dell'Angelo and Ospedale Ss Giovanni e Paolo, Mestre Venezia, Italy., De Gobbi M; Department of Clinical and Biological Sciences, Haematopoietic Stem Cell Transplant Unit, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy., Della Porta MG; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., De Simone M; Division of Hematology, Cardarelli Hospital, Napoli, Italy., Alati C; Division of Hematology, Azienda Ospedaliera ''Bianchi Melacrino Morelli', Reggio Calabria, Italy., Fracchiolla NS; UOC Oncoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Università degli Studi di Milano, Milan, Italy., Lunghi M; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Intermesoli T; Department of Oncology, Hematology University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Cardinali V; Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy., Mulè A; UOC, Ospedali Riuniti, Villa Sofia-Cervello, Palermo, Italy., Guarini A; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Chiaretti S; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2023 Nov-Dec; Vol. 64 (11), pp. 1884-1887. Date of Electronic Publication: 2023 Jul 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Fusion Proteins, bcr-abl*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Humans ; Adult ; Neoplasm, Residual/diagnosis ; Neoplasm, Residual/genetics ; Mutation ; Polymerase Chain Reaction ; Protein Kinase Inhibitors

المؤلفون: Shapiro RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA., Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Guleria I; Division of Renal Medicine, Renal Transplant Program, Brigham and Women's Hospital, Boston, MA., Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Kelkar A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

المصدر: Blood advances [Blood Adv] 2023 Aug 08; Vol. 7 (15), pp. 4080-4088.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*/epidemiology, Humans ; Cytokine Release Syndrome/etiology ; Retrospective Studies ; Bone Marrow Transplantation/adverse effects

المؤلفون: Soscia R; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.; GIMEMA Foundation, Rome, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Ilari C; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Ansuinelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Cavalli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Bellomarino V; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Cafforio L; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Di Trani M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Cazzaniga G; Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca/Fondazione MBBM, Monza, Italy., Fazio G; Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca/Fondazione MBBM, Monza, Italy., Santoro A; Division of Hematology and Bone Marrow Transplantation, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy., Salemi D; Division of Hematology and Bone Marrow Transplantation, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy., Spinelli O; Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy., Tosi M; Hematology and Bone Marrow Transplant Unit, Ospedale Papa Giovanni XXIII, Bergamo, Italy., Terragna C; Seràgnoli Institute of Hematology, Azienda Ospedaliero-Universitaria Sant'Orsola-Malpighi, Bologna, Italy., Robustelli V; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Bellissimo T; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Colafigli G; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Chiaretti S; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Di Rocco A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Martelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Guarini A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.; Department of Molecular Medicine, Sapienza University, Rome, Italy., Del Giudice I; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.

المصدر: Hematological oncology [Hematol Oncol] 2023 Feb; Vol. 41 (1), pp. 50-60. Date of Electronic Publication: 2022 Oct 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cell-Free Nucleic Acids* , Circulating Tumor DNA* , Hematologic Neoplasms*/diagnosis , Hematologic Neoplasms*/genetics , Leukemia, Lymphocytic, Chronic, B-Cell*, Humans ; Bias ; Biomarkers, Tumor/genetics

المؤلفون: Chiaretti S; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Taherinasab A; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy.; Fondazione GIMEMA Onlus, Rome, Italy., Canichella M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Ansuinelli M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., De Propris MS; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Messina M; Fondazione GIMEMA Onlus, Rome, Italy., Spinelli O; Haematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo., Santoro A; Department of Hemato Oncology, AOR 'VillaSofia-Cervello', Palermo, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Cardinali D; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Schipani M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Arena V; Fondazione GIMEMA Onlus, Rome, Italy., Bassan R; Division of Hematology, Ospedale dell'Angelo, Mestre, Venezia, Italy., Guarini A; Department of Molecular Medicine, 'Sapienza' University of Rome, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 483-486. Date of Electronic Publication: 2022 Dec 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology, Humans ; Adult ; Trans-Activators/genetics ; Gene Rearrangement

المؤلفون: Fazio F; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Cunsolo G; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Mancini F; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., De Propris MS; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Piciocchi A; GIMEMA Data Center, Rome, Italy., Arena V; GIMEMA Data Center, Rome, Italy., Messina M; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy.; GIMEMA Data Center, Rome, Italy., Ansuinelli M; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Taherinasab AT; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Apicella V; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Vitale A; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Chiaretti S; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Guarini A; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Del Giudice I; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy., Foà R; Department of Translational and Precision Medicine, Hematology, Sapienza University of Rome, Rome, Italy.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2022 Jun; Vol. 63 (6), pp. 1512-1514. Date of Electronic Publication: 2022 Feb 08.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis, Blast Crisis/diagnosis ; Humans ; Philadelphia Chromosome

المؤلفون: Marchesi, F., Capria, S., Giannarelli, D., Trisolini, S. M., Ansuinelli, M., Caputo, M. D., Serrao, A., Gumenyuk, S., Renzi, D., Pupo, L., Palombi, F., Provenzano, I., Di Rocco, A., Pisani, F., Romano, A., Spadea, A., Papa, E., Canfora, M., Cantonetti &, Mengarelli, A.

مصطلحات موضوعية: autologous stem cell transplantation, beam, lymphoma, autologous stem cell transplantation, beam, lymphoma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3686::3f2b54b980e6e6c2ebc7163a0a3a6b7a
http://hdl.handle.net/11573/1416564

المؤلفون: Ansuinelli M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.; GIMEMA Foundation, Rome, Italy., Lauretti A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Elia L; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Siravo V; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Messina M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Taherinasab A; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Canichella M; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Guarini A; Department of Molecular Medicine, Sapienza University, Rome, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Chiaretti S; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.

المصدر: Hematological oncology [Hematol Oncol] 2021 Dec; Vol. 39 (5), pp. 680-686. Date of Electronic Publication: 2021 Aug 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Philadelphia Chromosome*, Biomarkers, Tumor/*genetics , Fusion Proteins, bcr-abl/*genetics , Neoplasm Recurrence, Local/*pathology , Neoplasm, Residual/*pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*pathology , Real-Time Polymerase Chain Reaction/*methods, Disease Progression ; Humans ; Neoplasm Recurrence, Local/genetics ; Neoplasm, Residual/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Prognosis ; Reproducibility of Results